1. 1) Weidinger S, Novak N. Atopic dermatitis. Lancet, 387, 1109–1122 (2016).
2. 2) Simpson EL, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham NMH, Pirozzi G, Mastey V. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. J. Am. Dermatology., 74, 491–498 (2016).
3. 3) Bos JD, Kapsenberg ML, Smitt JH. Pathogenesis of atopic eczema. Lancet, 343, 1338–1341 (1994).
4. 4) Muller KM, Jaunin F, Masouye I, Saurat JH, Hauser C. Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol., 150, 5576–5584 (1993).
5. 5) Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol., 105, 860–876 (2000).